Air cargo plays a key role in the distribution of vaccines through well-established temperature-sensitive distribution systems, using cutting-edge technology and procedures.
This capability will prove crucial to the quick and efficient transport of COVID-19 vaccines once available. This will naturally require careful planning by every segment in the entire cargo supply chain to ensure full preparedness when vaccines for COVID-19 are approved and ready for distribution.
To guarantee the quality of the product, vaccines must be handled and transported in line with international regulatory and manufacturers’ requirements, at controlled temperatures, and without delay.
Priorities for developing capacity and resources for vaccine distribution include:
The availability of temperature-controlled facilities and appropriate equipment—maximizing the use or re-purposing of existing infrastructure and minimizing temporary builds;
The availability of staff trained to handle time and temperature-sensitive vaccines; and
The development of robust monitoring capabilities to ensure the integrity of the vaccines is maintained
~sIATA, 29 October 2020